Get notified of page updates
Stage 4 colorectal cancer
Clinicaltrials.gov identifier:NCT04895722
Combined Pembrolizumab & Quavonlimab (MK-1308A) Versus Other Treatments in People With MSI-High or dMMR Stage IV Colorectal Cancer
Stage 4 colorectal cancer
Clinicaltrials.gov identifier:NCT04895722
Glossary on
off
About the Study
This study is no longer recruiting patients.
The purpose of this study is to assess the efficacy and safety of co-formulated pembrolizumab/quavonlimab versus four other treatments in patients with Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient () ( IV) Colorectal Cancer.
This is phase 2, multi-arm, , study. Participants are placed into one of the five study groups by chance. All study participants will know which medication they are receiving during the study.
This Study is Open To:
This study is no longer recruiting patients.
This Study is NOT Open To:
This study is no longer recruiting patients.